Accendra Health (NYSE:ACH) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Accendra Health (NYSE:ACH) announced its quarterly earnings data on Monday. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02, FiscalAI reports. Accendra Health had a negative net margin of 39.84% and a negative return on equity of 13.18%. The firm had revenue of $627.78 million during the quarter.

Accendra Health Trading Up 2.2%

Shares of NYSE:ACH traded up $0.07 during trading hours on Wednesday, reaching $3.27. The stock had a trading volume of 671,600 shares, compared to its average volume of 1,075,873. Accendra Health has a 1 year low of $1.84 and a 1 year high of $9.55. The company has a market cap of $249.96 million, a PE ratio of -0.23, a P/E/G ratio of 3.16 and a beta of 1.70.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Zacks Research raised shares of Accendra Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. Robert W. Baird increased their price objective on Accendra Health from $5.00 to $6.00 and gave the company an “outperform” rating in a research note on Tuesday. UBS Group lifted their target price on Accendra Health from $3.00 to $4.50 and gave the company a “neutral” rating in a report on Tuesday. Citigroup boosted their target price on Accendra Health from $3.25 to $5.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Weiss Ratings began coverage on Accendra Health in a report on Wednesday, April 8th. They set a “sell (e+)” rating on the stock. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $5.17.

Hedge Funds Weigh In On Accendra Health

A number of institutional investors and hedge funds have recently modified their holdings of ACH. Keybank National Association OH acquired a new stake in Accendra Health in the first quarter valued at $46,000. Bank of New York Mellon Corp acquired a new position in shares of Accendra Health during the 1st quarter worth about $592,000. Dimensional Fund Advisors LP acquired a new position in shares of Accendra Health during the 1st quarter worth about $5,943,000. Hsbc Holdings PLC purchased a new position in shares of Accendra Health in the 1st quarter valued at about $34,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in shares of Accendra Health in the 1st quarter valued at about $239,000.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.